SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-224163
Filing Date
2022-08-18
Accepted
2022-08-18 16:41:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d294990d424b5.htm 424B5 448209
2 GRAPHIC g294990g01p04.jpg GRAPHIC 54502
3 GRAPHIC g294990g0813114321556.jpg GRAPHIC 3111
  Complete submission text file 0001193125-22-224163.txt   529204
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260859 | Film No.: 221177908
SIC: 8071 Services-Medical Laboratories